Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
48.15 USD | +8.32% | -.--% | +17.44% |
06-20 | Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit | MT |
06-20 | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | DJ |
- Stock Market
- Equities
- BSLN Stock
- BPMUF Stock
- News Basilea Pharmaceutica AG